Literature DB >> 3264805

Autocrine regulation of T-lymphocyte proliferation: differential induction of IL-2 and IL-2 receptor.

D A Cantrell1, M K Collins, M J Crumpton.   

Abstract

Three stimuli were used to compare the signals necessary for interleukin (IL-2) receptor expression and IL-2 production: triggering of the T-cell antigen receptor/CD3 complex (Ti/CD3) by CD3 antibodies, activation of protein kinase C (PKC) by phorbol esters, and elevation of intracellular calcium levels by calcium ionophore. The salient observations were that IL-2 responsiveness, which reflects IL-2 receptor expression, and T-cell proliferation which requires both IL-2 production and IL-2 receptor expression, are not co-ordinately regulated. Firstly, a low threshold of CD3 activation or a brief (1 hr) exposure of T cells to maximal CD3 stimulation is sufficient to induce IL-2 responsiveness, but higher levels of activation for a prolonged period are necessary to ensure a T-cell proliferative response. Secondly, in response to optimal T-cell stimulation there is a short (2-4 day) period of T-cell proliferation followed by a prolonged phase of IL-2 responsiveness (10-14 days). Differences in the kinetics and signalling requirements for IL-2 receptor expression and IL-2 production, regulated at the level of mRNA expression, provide a molecular basis for these observations. A major difference between induction of IL-2 production and IL-2 receptor expression is that the dual signals of calcium and PKC are necessary for IL-2 production, but a sole stimulus of PKC is sufficient for IL-2 receptor expression. Also, a low level stimulation of PKC will induce IL-2 receptor expression but higher levels of PKC stimulation are required for IL-2 production. As a consequence, triggering of a single receptor, namely the Ti/CD3 complex, results in IL-2 responsiveness, but an additional signal that activates PKC is necessary for IL-2 production. These observations suggest that a Ca2+/PKC dual signal model does not explain completely the signal transduction pathways that regulate T-cell growth. Moreover, precise regulatory mechanisms have evolved to control the homeostasis of the autocrine proliferative response of a T-cell population.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264805      PMCID: PMC1385470     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex.

Authors:  M Tsudo; R W Kozak; C K Goldman; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions.

Authors:  M Sharon; R D Klausner; B R Cullen; R Chizzonite; W J Leonard
Journal:  Science       Date:  1986-11-14       Impact factor: 47.728

3.  Expression of interleukin 2, interferon-gamma, and the IL 2 receptor by human peripheral blood lymphocytes.

Authors:  K Grabstein; S Dower; S Gillis; D Urdal; A Larsen
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

4.  The complete primary structure of protein kinase C--the major phorbol ester receptor.

Authors:  P J Parker; L Coussens; N Totty; L Rhee; S Young; E Chen; S Stabel; M D Waterfield; A Ullrich
Journal:  Science       Date:  1986-08-22       Impact factor: 47.728

5.  Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways.

Authors:  L Coussens; P J Parker; L Rhee; T L Yang-Feng; E Chen; M D Waterfield; U Francke; A Ullrich
Journal:  Science       Date:  1986-08-22       Impact factor: 47.728

6.  Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering.

Authors:  M Maruyama; H Shibuya; H Harada; M Hatakeyama; M Seiki; T Fujita; J Inoue; M Yoshida; T Taniguchi
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

7.  Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.

Authors:  K Teshigawara; H M Wang; K Kato; K A Smith
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

8.  Differential requirements for the induction of interleukin 2 responsiveness in L3T4+ and Lyt-2+ T cell subsets.

Authors:  F Erard; M Nabholz; A Dupuy-D'Angeac; H R MacDonald
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

9.  Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A.

Authors:  A Granelli-Piperno; L Andrus; R M Steinman
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

10.  Regulation of T cell autocrine growth. T4+ cells become refractory to interleukin 2.

Authors:  M Gullberg; K A Smith
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

View more
  16 in total

1.  Temporal protein expression pattern in intracellular signalling cascade during T-cell activation: a computational study.

Authors:  Piyali Ganguli; Saikat Chowdhury; Rupa Bhowmick; Ram Rup Sarkar
Journal:  J Biosci       Date:  2015-10       Impact factor: 1.826

2.  Self-induction of a/a or alpha/alpha biofilms in Candida albicans is a pheromone-based paracrine system requiring switching.

Authors:  Song Yi; Nidhi Sahni; Karla J Daniels; Kevin L Lu; Guanghua Huang; Thyagarajan Srikantha; David R Soll
Journal:  Eukaryot Cell       Date:  2011-04-15

3.  Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.

Authors:  B M Foxwell; J Simon; J J Herrero; D Taylor; G Woerly; D Cantrell; B Ryffel
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

4.  Role of interleukin-2 and interleukin-6 in the mitogen responsiveness of T cells from patients with 'common-variable' hypogammaglobulinaemia.

Authors:  M E North; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

5.  Lymphocyte adhesion and interactions with biomaterial adherent macrophages and foreign body giant cells.

Authors:  David T Chang; Erica Colton; Takehisa Matsuda; James M Anderson
Journal:  J Biomed Mater Res A       Date:  2009-12-15       Impact factor: 4.396

6.  Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness.

Authors:  R B Landewé; A M Miltenburg; M J Verdonk; C L Verweij; F C Breedveld; M R Daha; B A Dijkmans
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

7.  Immunosuppressive effects of Prevotella intermedia on in vitro human lymphocyte activation.

Authors:  B J Shenker; L Vitale; J Slots
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

8.  Altered gene transcription after burn injury results in depressed T-lymphocyte activation.

Authors:  A F Horgan; M V Mendez; D S O'Riordain; R G Holzheimer; J A Mannick; M L Rodrick
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

9.  Functional and molecular aspects of transient T cell unresponsiveness: role of selective interleukin-2 deficiency.

Authors:  M D Köller; H P Kiener; M Aringer; W B Graninger; S Meuer; Y Samstag; J S Smolen
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

10.  Defects in proliferative responses of T cells from patients with common variable immunodeficiency on direct activation of protein kinase C.

Authors:  M E North; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.